Viral evasion and subversion of pattern-recognition receptor signalling (original) (raw)

• Sadler, A. J. & Williams, B. R. Interferon-inducible antiviral effectors. Nature Rev. Immunol. 8, 559–568 (2008).
  CAS Google Scholar
• Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).
  CAS PubMed Google Scholar
• Ishii, K. J. et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nature Immunol. 7, 40–48 (2006).
  CAS Google Scholar
• Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505 (2007).
  CAS PubMed Google Scholar
• Wang, Z. et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl Acad. Sci. USA 105, 5477–5482 (2008).
  CAS PubMed PubMed Central Google Scholar
• Jin, M. S. & Lee, J. O. Structures of TLR-ligand complexes. Curr. Opin. Immunol. 29, 182–191 (2008).
  CAS Google Scholar
• Saito, T. & Gale, M. Jr. Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J. Exp. Med. 205, 1523–1527 (2008).
  CAS PubMed PubMed Central Google Scholar
• Takeuchi, O. & Akira, S. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20, 17–22 (2008).
  CAS PubMed Google Scholar
• O'Neill, L. A. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29, 12–20 (2008).
  CAS PubMed Google Scholar
• Zampieri, C. A., Sullivan, N. J. & Nabel, G. J. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nature Immunol. 8, 1159–1164 (2007).
  CAS Google Scholar
• Hartman, A. L., Ling, L., Nichol, S. T. & Hibberd, M. L. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J. Virol. 82, 5348–5358 (2008).
  CAS PubMed PubMed Central Google Scholar
• Beutler, B. et al. Genetic analysis of resistance to viral infection. Nature Rev. Immunol. 7, 753–766 (2007).
  CAS Google Scholar
• Kurt-Jones, E. A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol. 1, 398–401 (2000).
  CAS Google Scholar
• Bowie, A. et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl Acad. Sci. USA 97, 10162–10167 (2000). This is the first demonstration of viral proteins that inhibit TLRs.
  CAS PubMed PubMed Central Google Scholar
• Janeway, C. Jr. & Medzhitov, R. Viral interference with IL-1 and toll signaling. Proc. Natl Acad. Sci. USA 97, 10682–10683 (2000).
  CAS PubMed PubMed Central Google Scholar
• Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738 (2001).
  CAS PubMed Google Scholar
• Edelmann, K. H. et al. Does Toll-like receptor 3 play a biological role in virus infections? Virology 322, 231–238 (2004).
  CAS PubMed Google Scholar
• Schroder, M. & Bowie, A. G. TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26, 462–468 (2005).
  PubMed Google Scholar
• Vercammen, E., Staal, J. & Beyaert, R. Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin. Microbiol Rev. 21, 13–25 (2008).
  CAS PubMed PubMed Central Google Scholar
• Quintana-Murci, L., Alcais, A., Abel, L. & Casanova, J.-L. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nature Immunol. 8, 1165–1171 (2007).
  CAS Google Scholar
• Bowie, A. G. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin. Exp. Immunol. 147, 217–226 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513–520 (2003).
  CAS PubMed PubMed Central Google Scholar
• Krug, A. et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103, 1433–1437 (2004).
  CAS PubMed Google Scholar
• Jung, A. et al. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82, 196–206 (2008).
  CAS PubMed Google Scholar
• O'Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev. Immunol. 7, 353–364 (2007).
  CAS Google Scholar
• Pobezinskaya, Y. L. et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nature Immunol. 9, 1047–1054 (2008).
  CAS Google Scholar
• Michallet, M. C. et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28, 651–661 (2008).
  CAS PubMed Google Scholar
• Ermolaeva, M. A. et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nature Immunol. 9, 1037–1046 (2008).
  CAS Google Scholar
• Haga, I. R. & Bowie, A. G. Evasion of innate immunity by vaccinia virus. Parasitology 130, S11–S25 (2005).
  CAS PubMed Google Scholar
• Hurst, T. & Bowie, A. G. Innate immune signaling pathways: lessons from vaccinia virus. Future Virol. 3, 147–156 (2008).
  CAS Google Scholar
• Stack, J. et al. Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201, 1007–1018 (2005). This study shows that targeting of TIR-domain-containing adaptors by a VACV protein contributes to virulence, which predicts that TLRs have a role in host responses against poxviruses.
  CAS PubMed PubMed Central Google Scholar
• Carty, M. et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nature Immunol. 7, 1074–1081 (2006).
  CAS Google Scholar
• Newman, R. M., Salunkhe, P., Godzik, A. & Reed, J. C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74, 594–601 (2006).
  CAS PubMed PubMed Central Google Scholar
• Cirl, C. et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nature Med. 14, 399–406 (2008).
  CAS PubMed Google Scholar
• Li, K. et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl Acad. Sci. USA 102, 2992–2997 (2005). This is the first demonstration that HCV can target TLR3 by using the viral protease NS3–4A to cleave and disable TRIF.
• Abe, T. et al. Hepatitis C virus nonstructural protein 5A modulates the Toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 81, 8953–8966 (2007).
  CAS PubMed PubMed Central Google Scholar
• Harte, M. T. et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197, 343–351 (2003).
  CAS PubMed PubMed Central Google Scholar
• Keating, S. E., Maloney, G. M., Moran, E. M. & Bowie, A. G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFκB via activation of TRAF6 ubiquitination. J. Biol. Chem. 282, 33435–33443 (2007). This study shows that IRAK2 has a role in TLR-mediated NFκB activation, as a VACV protein potently inhibited NFκB by binding to IRAK2.
  CAS PubMed Google Scholar
• Kawagoe, T. et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nature Immunol. 9, 684–691 (2008). This study characterizes IRAK2-deficient mice and confirms the important role of IRAK2 in NFκB activation.
  CAS Google Scholar
• Datta, A., Sinha-Datta, U., Dhillon, N. K., Buch, S. & Nicot, C. The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages. J. Biol. Chem. 281, 23414–23424 (2006).
  CAS PubMed Google Scholar
• Wilson, J. R., de Sessions, P. F., Leon, M. A. & Scholle, F. West Nile Virus nonstructural protein 1 inhibits TLR-3 signal transduction. J. Virol. 82, 8262–8271 (2008).
  CAS PubMed PubMed Central Google Scholar
• Macdonald, A. & Harris, M. Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85, 2485–2502 (2004).
  CAS PubMed Google Scholar
• Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004).
  CAS Google Scholar
• Yoneyama, M. et al. Shared and unique functions of the DExD/H-Box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851–2858 (2005).
  CAS PubMed Google Scholar
• Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, MDA-5, and inhibit its activation of the _IFN_-β promoter. Proc. Natl Acad. Sci. USA 101, 17264–17269 (2004).
  CAS PubMed PubMed Central Google Scholar
• Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunol. 6, 981–988 (2005).
  CAS Google Scholar
• Seth, R. B., Sun, L., Ea, C.-K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122, 669–682 (2005).
  CAS PubMed Google Scholar
• Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005). This study reveals that the target of the HCV protease NS3–4A in the RIG-I pathway is the RIG-I adaptor IPS1.
  CAS PubMed Google Scholar
• Xu, L.-G. et al. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19, 727–740 (2005).
  CAS PubMed Google Scholar
• Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678 (2008).
  CAS PubMed PubMed Central Google Scholar
• Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006).
  CAS PubMed Google Scholar
• Hornung, V. et al. 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006). References 51 and 52 show that the ligand for RIG-I is ssRNA with a 5′-triphosphate, and this was discovered partly based on the analysis of the mechanism by which influenza virus protein NS1 inhibits RIG-I.
  PubMed Google Scholar
• Cui, S. et al. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol. Cell 29, 169–179 (2008).
  CAS PubMed Google Scholar
• Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523–527 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601–1610 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gitlin, L. et al. Essential role of MDA-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103, 8459–8464 (2006).
  CAS PubMed PubMed Central Google Scholar
• Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006).
  CAS PubMed Google Scholar
• Plotch, S. J., Bouloy, M., Ulmanen, I. & Krug, R. M. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23, 847–858 (1981).
  CAS PubMed Google Scholar
• Habjan, M. et al. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3, e2032 (2008).
  PubMed PubMed Central Google Scholar
• Flanegan, J. B., Petterson, R. F., Ambros, V., Hewlett, N. J. & Baltimore, D. Covalent linkage of a protein to a defined nucleotide sequence at the 5′-terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl Acad. Sci. USA 74, 961–965 (1977).
  CAS PubMed PubMed Central Google Scholar
• Lee, Y. F., Nomoto, A., Detjen, B. M. & Wimmer, E. A protein covalently linked to poliovirus genome RNA. Proc. Natl Acad. Sci. USA 74, 59–63 (1977).
  CAS PubMed PubMed Central Google Scholar
• Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R. & Paludan, S. R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059–5064 (2006).
  CAS PubMed PubMed Central Google Scholar
• Haasnoot, J. et al. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3, e86 (2007).
  PubMed PubMed Central Google Scholar
• Weeks, K. M., Ampe, C., Schultz, S. C., Steitz, T. A. & Crothers, D. M. Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249, 1281–1285 (1990).
  CAS PubMed Google Scholar
• Brand, S. R., Kobayashi, R. & Mathews, M. B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272, 8388–8395 (1997).
  CAS PubMed Google Scholar
• Mibayashi, M. et al. inhibition of retinoic acid-inducible gene I-mediated induction of β interferon by the NS1 protein of influenza A virus. J. Virol. 81, 514–524 (2007).
  CAS PubMed Google Scholar
• Barral, P. M. et al. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81, 3677–3684 (2007).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl Acad. Sci. USA 104, 7253–7258 (2007).
  CAS PubMed PubMed Central Google Scholar
• Loo, Y. M. et al. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc. Natl Acad. Sci. USA 103, 6001–6006 (2006).
  CAS PubMed PubMed Central Google Scholar
• Lin, R. et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKɛ molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3–4A proteolytic cleavage. J. Virol. 80, 6072–6083 (2006). References 68–70 show that HCV protease NS3–4A cleaves IPS1 from the mitochondrial membrane, which defined the mechanism of action of NS3–4A and showed that IPS1 needs to be attached to mitochondria to mediate antiviral responses.
  CAS PubMed PubMed Central Google Scholar
• Stetson, D. B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93–103 (2006).
  CAS PubMed Google Scholar
• Okabe, Y., Kawane, K., Akira, S., Taniguchi, T. & Nagata, S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202, 1333–1339 (2005).
  CAS PubMed PubMed Central Google Scholar
• Nociari, M., Ocheretina, O., Schoggins, J. W. & Falck-Pedersen, E. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 81, 4145–4157 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ishii, K. J. et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451, 725–729 (2008).
  CAS PubMed Google Scholar
• Otsuka, M. et al. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41, 1004–1012 (2005).
  CAS PubMed Google Scholar
• DiPerna, G. et al. Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279, 36570–36578 (2004).
  CAS PubMed Google Scholar
• Unterstab, G. et al. Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1. Proc. Natl Acad. Sci. USA 102, 13640–13645 (2005).
  CAS PubMed PubMed Central Google Scholar
• Brzozka, K., Finke, S. & Conzelmann, K.-K. Identification of the rabies virus α/β interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79, 7673–7681 (2005).
  CAS PubMed PubMed Central Google Scholar
• Alff, P. J., Sen, N., Gorbunova, E., Gavrilovskaya, I. N. & Mackow, E. R. The NY-1 hantavirus Gn cytoplasmic tail co-precipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK–TRAF3 complex formation. J. Virol. 80, 9676–9686 (2008).
  Google Scholar
• Devaraj, S. G. et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282, 32208–32221 (2007).
  CAS PubMed Google Scholar
• Schroder, M., Baran, M. & Bowie, A. G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKvarɛ-mediated IRF activation. Embo J. 27, 2147–2157 (2008). This study provides an elegant example of how defining mechanisms of viral evasion can identify host proteins with a role in PRR signalling: VACV K7R was shown to inhibit IFN expression by targeting DDX3.
  PubMed PubMed Central Google Scholar
• Soulat, D. et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Embo J. 27, 2135–2146. (2008). This study confirms the role of DDX3 in the induction of IFN production.
  CAS PubMed PubMed Central Google Scholar
• Lu, L. L., Puri, M., Horvath, C. M. & Sen, G. C. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of κB kinase ɛ (IKKɛ)/TBK1. J. Biol. Chem. 283, 14269–14276 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lin, R. et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20, 800–811 (2001).
  CAS PubMed Google Scholar
• Joo, C. H. et al. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 81, 8282–8292 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lefort, S., Soucy-Faulkner, A., Grandvaux, N. & Flamand, L. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J. Virol. 81, 10950–10960 (2007).
  CAS PubMed PubMed Central Google Scholar
• Melroe, G. T., Silva, L., Schaffer, P. A. & Knipe, D. M. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-β induction. Virology 360, 305–321 (2007).
  CAS PubMed Google Scholar
• Saira, K., Zhou, Y. & Jones, C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits β interferon promoter activity. J. Virol. 81, 3077–3086 (2007).
  CAS PubMed PubMed Central Google Scholar
• Okumura, A. et al. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373, 85–97 (2008).
  CAS PubMed Google Scholar
• Bauhofer, O. et al. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J. Virol. 81, 3087–3096 (2007).
  CAS PubMed PubMed Central Google Scholar
• Barro, M. & Patton, J. T. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J. Virol. 81, 4473–4481 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lu, G. et al. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell. Mol. Biol. (Noisy-le-grand) 52, 29–41 (2006).
  CAS Google Scholar
• Guerra, S., Caceres, A., Knobeloch, K. P., Horak, I. & Esteban, M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4, e1000096 (2008).
  PubMed PubMed Central Google Scholar
• Hiscott, J., Nguyen, T. L., Arguello, M., Nakhaei, P. & Paz, S. Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 25, 6844–6867 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tait, S. W., Reid, E. B., Greaves, D. R., Wileman, T. E. & Powell, P. P. Mechanism of inactivation of NF-κB by a viral homologue of IκBα. Signal-induced release of IκBα results in binding of the viral homologue to NF-κB. J. Biol. Chem. 275, 34656–34664 (2000).
  CAS PubMed Google Scholar
• Rodriguez, C. I. et al. African swine fever virus IAP-like protein induces the activation of nuclear factor κB. J. Virol. 76, 3936–3942 (2002).
  CAS PubMed PubMed Central Google Scholar
• Chen, R. A. J., Ryzhakov, G., Cooray, S., Randow, F. & Smith, G. L. Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4, e22 (2008).
  PubMed PubMed Central Google Scholar
• Matta, H. et al. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IκB kinase complex to selectively activate NF-κB without JNK activation. J. Biol. Chem. 282, 24858–24865 (2007).
  CAS PubMed Google Scholar
• Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Med. 10, 1366–1373 (2004).
  CAS PubMed Google Scholar
• Le Goffic, R. et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53 (2006).
  PubMed Google Scholar
• Hutchens, M. et al. TLR3 increases disease morbidity and mortality from vaccinia infection. J. Immunol. 180, 483–491 (2008). References 99–101 show that for three distinct viruses the absence of TLR3 benefits the host, suggesting that some viruses actually use TLR3 to facilitate viral dissemination.
  Google Scholar
• Gowen, B. B. et al. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 177, 6301–6307 (2006).
  CAS PubMed Google Scholar
• Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007). This is a rare demonstration of the importance of a PRR in human viral disease.
  CAS PubMed Google Scholar
• Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nature Med. 12, 1301–1309 (2006).
  CAS PubMed Google Scholar
• Ejrnaes, M. et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461–2472 (2006).
  CAS PubMed PubMed Central Google Scholar
• Maloney, G., Schroder, M. & Bowie, A. G. Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10. J. Biol. Chem. 280, 30838–30844 (2005).
  CAS PubMed Google Scholar
• Jude, B. A. et al. Subversion of the innate immune system by a retrovirus. Nature Immunol. 4, 573–578 (2003). This study shows that viruses can subvert TLRs to complete their life cycle.
  CAS Google Scholar
• Ariumi, Y. et al. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81, 13922–13926 (2007).
  CAS PubMed PubMed Central Google Scholar
• Yedavalli, V. S. R. K., Neuveut, C., Chi, Y.-H., Kleiman, L. & Jeang, K.-T. Requirement of DDX3 DEAD Box RNA helicase for HIV-1 Rev-RRE export function. Cell 119, 381–392 (2004).
  CAS PubMed Google Scholar
• Awomoyi, A. A. et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J. Immunol. 179, 3171–3177 (2007).
  CAS PubMed Google Scholar
• Johnson, C. L., Owen, D. M. & Gale, M. Jr. Functional and therapeutic analysis of hepatitis c virus NS3.4a protease control of antiviral immune defense. J. Biol. Chem. 282, 10792–10803 (2007).
  CAS PubMed Google Scholar
• Cardenas, W. B. et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits α/β interferon production induced by RIG-I signaling. J. Virol. 80, 5168–5178 (2006).
  CAS PubMed PubMed Central Google Scholar
• Gale, M. J. Jr et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217–227 (1997).
  CAS PubMed Google Scholar
• Taguchi, T. et al. Hepatitis C virus NS5A protein interacts with 2′, 5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J. Gen. Virol. 85, 959–969 (2004).
  CAS PubMed Google Scholar
• Chang, H. W., Watson, J. C. & Jacobs, B. L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl Acad. Sci. USA 89, 4825–4829 (1992).
  CAS PubMed PubMed Central Google Scholar
• Romano, P. R. et al. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18, 7304–7316 (1998).
  CAS PubMed PubMed Central Google Scholar
• Hatada, E. & Fukuda, R. Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325–3329 (1992).
  CAS PubMed Google Scholar